Navigation Links
USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Date:1/29/2008

Eliminates the Need for Translation of Compendia Used to Ensure the Quality of Pharmaceutical and Over-the-Counter Medications

ROCKVILLE, Md., Jan. 29 /PRNewswire-USNewswire/ -- The U.S. Pharmacopeia is pleased to announce that the third annual Spanish edition of its core compendia, the United States Pharmacopeia and National Formulary (USP-NF), is now available for purchase. The official edition for 2008, USP 31-NF 26, provides specifications needed to produce more than 4,000 quality pharmaceuticals, excipients, dietary supplements, biologics and other therapeutics.

USP-NF, recognized by U.S. federal law as the country's official compendia for drug standards, offers access to monographs defining the required standards for the identity, quality, purity, strength, labeling and packaging for pharmaceutical and over-the-counter medications, dietary supplements, and other health care products. These standards are enforceable by the U.S. Food and Drug Administration for drugs marketed in or exported to the United States, and are also recognized by governments and regulatory agencies throughout the world.

"USP is proud to offer a Spanish edition of the USP-NF for the third year in a row," said Darrell Abernethy, M.D., Ph.D., chief science officer of USP. "By translating the compendia, we hope to better meet the needs of our Spanish-speaking partners as we work together to advance USP's mission of providing good pharmaceutical care for all people, all over the world."

The Spanish edition is an official, expert translation of the USP-NF in English. Written in a universal, neutral Spanish, the translation process is supervised by USP's Spanish Advisory Panel -- a dedicated body of leading scientific experts from Spanish-speaking countries. USP offers expert scientific and technical support in Spanish during business hours that are convenient for Spanish-speaking customers.

USP-NF is used by quality assurance and quality con
'/>"/>

SOURCE U.S. Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. Latin American adolescents are more likely to become infected with HIV than Spanish

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... , Benton Communications ...siness growth system for retailers struggling to m... (PRWEB) November 26, 2009 -- Flu fears is the t...les to the emergency room, according to Dr. David ...ewly released business growth system – The ...
(Date:11/25/2009)... ,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sen...esonanceImaging(MRI)coilsandsoftwareandCalgaryScie...ologies,haveintroducedawebversionofAegis(TM)Breast...iveinterfaceisthefirsttrulyzero-footprintWebclient...ntific,sPureWeb(TM)platformallowsforzero-footprint...
(Date:11/25/2009)... ,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayA...sfirst Winter Spare the Air Alert fo...facturedfirelogsoranyothersolidfuel,bothindoorsand...unhealthyairqualitytomorrow,"saidJackBroadbent,exe...esidentstorespectthehealthoftheirneighborsandfello...
(Date:11/25/2009)... , Does stress increase blood pressure? This sim...h for many years. New Stress-related gene Modulat... increase blood pressure? This simple question ha...s. Now new research has for the first time establ...the blood pressure response to stress in mice as w...
(Date:11/25/2009)... Survivors often plagued by neurological symptoms...ealthDay News) -- Neurological side effects are am...ivors of testicular cancer who were treated with c.... , The study included 1,409 Norwegian men trea...and 1994 who took part in a follow-up survey condu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...day,announced the first true single port laparosco...tem., At Baystate Medical Center, Springfield, MA...Surgery, performed a gallbladder removal procedure...eals. This provides unobstructed access to the cav...
...n and Adults With Dis...ream Corporation,today announced results of its 27...ser to benefit Easter Seals. Since the conclusion ...se dollars,were raised during the chain-wide ,Cone...
...y,(NYSE: LLY ) today announced that the European ...EO(R) (teriparatide [rDNA origin] injection) for t...ined, systemic,glucocorticoid therapy in women and... Human Use (CHMP) of the European,Medicines Evalua...
...ording Artist Chaka Khan, LOS ANGELES, April 3, 2...millionth visitor to BODY WORLDS today. This marks...eaking run for BODY WORLDS,at the California Scien...onsored by her foundation, were at the,exhibit whe...
...er the incidents , , THURSDAY, April 3 (He...tner violence suffer a wide range of physical and ...zation study that included 25,000 women in 11 coun...d Republic of Tanzania.,The study found that havin...
... to join Harvard University,s Ash Institute for De... the bi-annual conference,Frontiers of Innovation:...ridge March 31st through today. On Monday evening,... neglected,diseases and in disaster preparedness i...
Other Medicine News:Health News:SurgiQuest Announces First Procedure Using AirSeal(TM) Access System 2Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2
(Date:11/24/2009)...ia/--ChindexInternational,Inc.,("Chindex")(Nasdaq:...rn,healthcareproductsandservicesinthePeople,sRepub...the21stAnnualPiperJaffray,"Unplugged"HealthCareCon...ceHotel. , Managementiscurrentlyscheduledtopr...ne-on-onemeetingsthroughouttheday.Awebcast,ofthepr...
(Date:11/24/2009)...FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ...dDisclosureStatementtoday,November24,2009,withtheU....AhearingtoconsiderapprovaloftheDisclosureStatemen...ingontheconfirmationofthePlanscheduledforJanuary7,...sinfull.ThePlanisexpected,ifapproved,toallowholder...
(Date:11/24/2009)...re-FirstCall/--ThoratecCorporation(Nasdaq: THOR ),...porttherapiestosave,supportandrestorefailinghearts...PiperJaffrayHealthCareConferenceonTuesday,December...effinancialofficer,willprovideanupdateonthecompany...PacificStandardTime). ,, Thepresentationwillbea...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 1Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 1Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 2Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 4Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 5
... Myeloma Workshop held in,Kos, Greece demonstrates...th bortezomib, dexamethasone and lenalidomide plus...ry multiple,myeloma, and as a single agent in pati...lobulinemia, NEW YORK, June 29, 2007 /PRNewswire-F...announced that 4 posters were,presented at the 11t...
... vaccine has shown 90%,efficacy for prevention of ...d with the human papillomavirus (HPV) types target...published early Online,and in the upcoming issue o... or more,cases of cervical cancer worldwide, but t...ntribute to cervical cancer. , Professor Jorma Paa...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: